Eli Lilly (LLY)’s Pharmaceutical Leadership as a Driver of Consistent Dividends

Core Insights - Eli Lilly and Company (NYSE:LLY) is recognized as one of the 13 Best Consistent Dividend Stocks to Buy Now [1] Group 1: Pharmaceutical Leadership - Eli Lilly is expected to maintain its leadership in the expanding weight-loss market through the end of the decade, with its drug tirzepatide projected to generate nearly $62 billion in sales by 2030 [2] - The company has a strong pipeline, with Orforglipron showing promising results in helping diabetes patients lower A1C levels and lose weight, which supports future revenue growth [3] Group 2: Dividend History - Eli Lilly has a solid dividend history, with 11 years of dividend growth, making it one of the best dividend stocks [4] - The company currently offers a quarterly dividend of $1.50 per share, resulting in a dividend yield of 0.79% as of September 12 [4]